Affordable Access

Publisher Website

Susceptibility of Health Care Students to Measles, Paris, France

Centers for Disease Control and Prevention
Publication Date
DOI: 10.3201/eid1709.110141
  • Letters To The Editor
  • Medicine


Letters.indd LETTERS References 1. Oh JY, Bancroft JE, Cunningham MC, Keene WE, Lyss SB, Cieslak PR, et al. Comparison of survey methods in norovi- rus outbreak investigation, Oregon, USA. Emerg Infect Dis. 2010;16:1773–6. 2. Zuckerberg M. 500 million stories. July 21, 2010 [cited 2010 Dec 22]. http://blog.face- 3. Sax L, Gilmartin S, Bryant A. As- sessing response rates and nonre- sponse bias in Web and paper surveys. Res Higher Educ. 2003;44:409–32. doi:10.1023/A:1024232915870 Address for correspondence: Julia F. Howland, Division of Infectious Diseases, Illinois Department of Public Health, 7th Floor, 122 S Michigan Ave, Chicago, IL 60602, USA; email: [email protected] Susceptibility of Health Care Students to Measles, Paris, France To the Editor: A measles epidemic is currently occurring in several countries in Europe (1,2). Although most cases concern unvaccinated children and young adults, health care professionals (HCPs) are also affected. Cases occur mostly in unvaccinated persons, but also in those who have received a single dose of vaccine. In France, the measles vaccine was introduced in the childhood- immunization schedule in 1983. Current guidelines recommend 2 doses: one at 12 months of age and the second between 13 and 24 months of age. For persons born after 1992, one catch-up dose is recommended (3). Coverage by >1 dose, by the age of 2 years, remained at 83%–87% during 1997–2005. The latest fi gures show a slight increase to 90% in 2007 (4). The risk for measles in HCPs has been estimated as 13× higher than that for the general population (5) and is also higher among students (6). Vaccination against measles is recommended, not mandatory, for HCPs and health care students (HCSs) (medicine, nursing, and midwifery) who have no history of measles. The objective is to prevent transmission to a nonimmunized patient or another HCP, and from patients to susce

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times